Literature DB >> 11462185

Antibiotic selection of multiply resistant pneumococci.

K P Klugman1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11462185     DOI： 10.1086/322736

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  8 in total

1.  Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008.

Authors:  Penny Crowther-Gibson; Cheryl Cohen; Keith P Klugman; Linda de Gouveia; Anne von Gottberg
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

2.  Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000.

Authors:  Donald E Low; Joyce de Azavedo; Karl Weiss; Tony Mazzulli; Magdalena Kuhn; Deirdre Church; Kevin Forward; George Zhanel; Andrew Simor; A McGeer
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

3.  Intrinsic epidemicity of Streptococcus pneumoniae depends on strain serotype and antibiotic susceptibility pattern.

Authors:  Matthieu Domenech de Cellès; Lulla Opatowski; Jérôme Salomon; Emmanuelle Varon; Claude Carbon; Pierre-Yves Boëlle; Didier Guillemot
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

4.  Drug-resistant Streptococcus pneumoniae in Community-acquired Pneumonia.

Authors:  Michael Henry; Howard L. Leaf
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

5.  Risk factors for development of multiple-class resistance to Streptococcus pneumoniae Strains in Belgium over a 10-year period: antimicrobial consumption, population density, and geographic location.

Authors:  Johan Van Eldere; Robertino M Mera; Linda A Miller; James A Poupard; Heather Amrine-Madsen
Journal:  Antimicrob Agents Chemother       Date:  2007-08-06       Impact factor: 5.191

6.  Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi.

Authors:  Dean B Everett; Mavuto Mukaka; Brigitte Denis; Stephen B Gordon; Enitan D Carrol; Joep J van Oosterhout; Elizabeth M Molyneux; Malcolm Molyneux; Neil French; Robert S Heyderman
Journal:  PLoS One       Date:  2011-03-15       Impact factor: 3.240

Review 7.  Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective.

Authors:  Stephan Harbarth; Werner Albrich; Christian Brun-Buisson
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

8.  Population structure, epidemiology and antibiotic resistance patterns of Streptococcus pneumoniae serotype 5: prior to PCV-13 vaccine introduction in Eastern Gambia.

Authors:  Eta E Ashu; Sheikh Jarju; Michel Dione; Grant Mackenzie; Usman N Ikumapayi; Ahmed Manjang; Romuladus Azuine; Martin Antonio
Journal:  BMC Infect Dis       Date:  2016-01-28       Impact factor: 3.090
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.